CK-MB Detection Kit

Description

The CK-MB (Creatine Kinase Isoenzymes MB) detection kit is a specialized diagnostic tool designed for the precise quantitative measurement of CK-MB levels in human serum. It plays a critical role in diagnosing myocardial infarction (MI) and other cardiac conditions. The kit employs an advanced chemiluminescence immunoassay (CLIA) method based on the sandwich principle, enabling a wide detection range from 0.1 to 250.0 ng/mL.

Key features include its compatibility with multiple chemiluminescence analyzers and calibration traceable to the Beckman CK-MB assay, ensuring high precision and consistency in results. The test demonstrates exceptional sensitivity, allowing for the detection of CK-MB levels as early as 4–6 hours after symptom onset, with peak levels observed at 18–24 hours. Strict sample preparation protocols ensure reliable results, but it is crucial to interpret findings alongside clinical evaluations for accurate diagnosis. This kit is a valuable addition to cardiac diagnostic workflows, enhancing early intervention and patient care.